GLP-1 receptor agonists work by stimulating insulin release in response to high blood sugar levels, inhibiting glucagon release after meals, and slowing gastric emptying to help decrease appetite and food intake
In my practice I have seen patients make similar gains to semaglutide, even while staying on lower doses of tirzepatide
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis
How does retatrutide affect alcohol metabolism
While its safety profile was consistently favorable, the largest Phase IIb trial failed to show statistical significance for weight loss, and commercial development was halted in 2007.[2] Despite this, interest in AOD-9604 has continued in the compounding pharmacy and integrative medicine space, particularly given its safety data, its lack of IGF-1 stimulation, and emerging research around joint health